Search
Showing results for "1"
Research
Two females with mutations in USP9X highlight the variable expressivity of the intellectual disability syndromeThe genetic causes of intellectual disability (ID) are heterogeneous and include both chromosomal and monogenic etiologies.
Research
Short-term changes in frequencies of circulating leukocytes associated with narrowband UVB phototherapy in people with clinically isolated syndromeSince B cells are increasingly targeted by MS therapies, the effects of narrowband UVB phototherapy in people with MS should be investigated further
Research
Declining transition rates to psychotic disorder in "ultra-high risk" clients: Investigation of a dilution effectLater ultra-high risk psychosis cohorts presented with different clinical intake characteristics than earlier cohorts
Research
Is Streptococcus pyogenes resistant or susceptible to trimethoprim- sulfamethoxazole?Streptococcus pyogenes is commonly believed to be resistant to trimethoprim-sulfamethoxazole (SXT), resulting in reservations about using SXT for skin and...
News & Events
Help our kids reach their potentialYou're invited to join the Early Childhood Development and Learning Collaboration on Monday 15 August from 7pm to help every child reach their potential.
This role will be responsible for independently conducting research into the interaction between type 1 diabetes and exercise.
Research
Development of a Model of Care resource for FASD in the justice systemThis article describes the development of a Model of Care resource to support youth involved with the justice system where a neurodevelopmental disability such as Fetal Alcohol Spectrum Disorder is suspected. Service staff within the Youth Justice sector were engaged in an iterative process of resource development over a 9-month period.
News & Events
Oral insulin studyDiabetes researchers from Perth Children’s Hospital would like to find out whether oral insulin is useful in T1D management and is safe for use in individuals with T1D. They are looking for participants aged 16 – 25 years to be involved in their Oral Insulin 12-week study.